Why are most phospholipidosis inducers also hERG blockers?
Crossref DOI link: https://doi.org/10.1007/s00204-017-1995-9
Published Online: 2017-05-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Slavov, Svetoslav
Stoyanova-Slavova, Iva
Li, Shuaizhang
Zhao, Jinghua
Huang, Ruili
Xia, Menghang
Beger, Richard
License valid from 2017-05-27